Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Hepatitis Reports|October 16, 2010
The Role of Interferon in Hepatitis B TherapyVincent Rijckborst, Harry L A JanssenJournal of Medical Virology|September 15, 2011
HBV DNA suppression in HBeAg-positive chronic hepatitis B patients treated with peginterferon or placeboBettina E Hansen, Vincent Rijckborst, Martijn J Ter Borg, et al.Hepatology (Baltimore, Md.)|September 11, 2010
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen declineMilan J Sonneveld, Vincent Rijckborst, Charles A B Boucher, et al.Nederlands Tijdschrift Voor Geneeskunde|November 1, 2018
[Pregnancy and lever cirrhosis: a high-risk combination]Vincent Rijckborst, Jildou Hoekstra, Marian M H Claessen, et al.European Journal of Gastroenterology & Hepatology|April 27, 2016
Short article: Management of ruptured hepatocellular carcinoma in a European tertiary care centerVincent Rijckborst, Martijn J Ter Borg, Eric T Tjwa, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 20, 2011
A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis BMilan J Sonneveld, Vincent Rijckborst, Charles A B Boucher, et al.Journal of Hepatology|November 30, 2010
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavirJurriën G P Reijnders, Vincent Rijckborst, Milan J Sonneveld, et al.Hepatology (Baltimore, Md.)|February 7, 2012
Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis BMilan J Sonneveld, Vincent Rijckborst, Stefan Zeuzem, et al.Journal of Hepatology|August 14, 2012
Identification and treatment of chronic hepatitis B in Chinese migrants: results of a project offering on-site testing in Rotterdam, The NetherlandsIrene K Veldhuijzen, Reinoud Wolter, Vincent Rijckborst, et al.Antiviral Therapy|January 24, 2012
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotypeMilan J Sonneveld, Vincent Rijckborst, Yilmaz Cakaloglu, et al.Pageof 2